T45 Labs is a MedTech Incubator based in Silicon Valley, specializing in developing minimally invasive technologies for the cardiovascular market. Our strategy focuses on minimizing risks and maximizing returns through a fast-follower approach. We manage the T45 Fund I, a direct investment vehicle supporting Series A and Series B stages in our portfolio companies. Our team comprises experienced executives and engineers, leveraging their expertise in MedTech investments and development to drive innovation.